These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 21256803

  • 1. Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia.
    Uchiyama M, Hamamura M, Kuwano T, Nishiyama H, Nagata H, Uchimura N.
    Sleep Med; 2011 Feb; 12(2):119-26. PubMed ID: 21256803
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and efficacy of ramelteon in Japanese patients with chronic insomnia.
    Uchiyama M, Hamamura M, Kuwano T, Nagata H, Hashimoto T, Ogawa A, Uchimura N.
    Sleep Med; 2011 Feb; 12(2):127-33. PubMed ID: 21277255
    [Abstract] [Full Text] [Related]

  • 3. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T, Seiden D, Sainati S, Wang-Weigand S, Zhang J, Zee P.
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.
    Zammit G, Erman M, Wang-Weigand S, Sainati S, Zhang J, Roth T.
    J Clin Sleep Med; 2007 Aug 15; 3(5):495-504. PubMed ID: 17803013
    [Abstract] [Full Text] [Related]

  • 5. A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.
    Roth T, Seiden D, Wang-Weigand S, Zhang J.
    Curr Med Res Opin; 2007 May 15; 23(5):1005-14. PubMed ID: 17519067
    [Abstract] [Full Text] [Related]

  • 6. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.
    Mini L, Wang-Weigand S, Zhang J.
    Clin Ther; 2008 Jul 15; 30(7):1316-23. PubMed ID: 18691991
    [Abstract] [Full Text] [Related]

  • 7. Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis.
    Wang-Weigand S, McCue M, Ogrinc F, Mini L.
    Curr Med Res Opin; 2009 May 15; 25(5):1209-13. PubMed ID: 19327100
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.
    Uchimura N, Ogawa A, Hamamura M, Hashimoto T, Nagata H, Uchiyama M.
    Expert Rev Neurother; 2011 Feb 15; 11(2):215-24. PubMed ID: 21306209
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia.
    Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M.
    Sleep; 2009 Mar 15; 32(3):351-60. PubMed ID: 19294955
    [Abstract] [Full Text] [Related]

  • 10. Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study.
    Richardson GS, Zammit G, Wang-Weigand S, Zhang J.
    J Clin Psychiatry; 2009 Apr 15; 70(4):467-76. PubMed ID: 19284927
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of ramelteon for insomnia symptoms in older adults with obstructive sleep apnea: a randomized placebo-controlled pilot study.
    Gooneratne NS, Gehrman P, Gurubhagavatula I, Al-Shehabi E, Marie E, Schwab R.
    J Clin Sleep Med; 2010 Dec 15; 6(6):572-80. PubMed ID: 21206546
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of ramelteon in a double-blind, placebo-controlled, crossover study in Japanese patients with chronic primary insomnia.
    Kohsaka M, Kanemura T, Taniguchi M, Kuwahara H, Mikami A, Kamikawa K, Uno H, Ogawa A, Murasaki M, Sugita Y.
    Expert Rev Neurother; 2011 Oct 15; 11(10):1389-97. PubMed ID: 21955196
    [Abstract] [Full Text] [Related]

  • 13. The effects of ramelteon in a first-night model of transient insomnia.
    Zammit G, Schwartz H, Roth T, Wang-Weigand S, Sainati S, Zhang J.
    Sleep Med; 2009 Jan 15; 10(1):55-9. PubMed ID: 18691937
    [Abstract] [Full Text] [Related]

  • 14. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ, Wang-Weigand S, Zhang J.
    Am J Geriatr Pharmacother; 2007 Sep 15; 5(3):177-84. PubMed ID: 17996657
    [Abstract] [Full Text] [Related]

  • 15. Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis.
    Kuriyama A, Honda M, Hayashino Y.
    Sleep Med; 2014 Apr 15; 15(4):385-92. PubMed ID: 24656909
    [Abstract] [Full Text] [Related]

  • 16. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
    Wang-Weigand S, Watissée M, Roth T.
    Sleep Med; 2011 Oct 15; 12(9):920-3. PubMed ID: 21925941
    [Abstract] [Full Text] [Related]

  • 17. Ramelteon for the treatment of insomnia.
    Borja NL, Daniel KL.
    Clin Ther; 2006 Oct 15; 28(10):1540-55. PubMed ID: 17157111
    [Abstract] [Full Text] [Related]

  • 18. Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis.
    Liu J, Wang LN.
    Int J Clin Pract; 2012 Sep 15; 66(9):867-73. PubMed ID: 22897464
    [Abstract] [Full Text] [Related]

  • 19. The Effect of Ramelteon on Heartburn Symptoms of Patients With Gastroesophageal Reflux Disease and Chronic Insomnia: A Pilot Study.
    Jha LK, Fass R, Gadam R, Maradey-Romero C, Nasrollah L, Hershcovici T, Quan SF, Dickman R.
    J Clin Gastroenterol; 2016 Feb 15; 50(2):e19-24. PubMed ID: 25887111
    [Abstract] [Full Text] [Related]

  • 20. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M, Seiden D, Zammit G, Sainati S, Zhang J.
    Sleep Med; 2006 Jan 15; 7(1):17-24. PubMed ID: 16309958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.